Covid-19 roundup: Swiss biotech halts in-pa­tient PhII study; Hous­ton-based vac­cine and Chi­nese mR­NA shot nab EUAs in In­done­sia

An­oth­er Covid-19 study is hit­ting the brakes as a Swiss biotech is paus­ing its Phase II tri­al in pa­tients hos­pi­tal­ized with Covid-19.

Ki­narus Ther­a­peu­tics an­nounced …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.